Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis
Study to Assess the Efficacy and Safety of SK-MS10 in Subjects With Acute and Chronic Gastritis
The purpose of this study is to Assess the Efficacy and Safety of SK-MS10 in subjects With
 acute and chronic gastritis.
Inclusion Criteria:

 1. Have been diagnosed as erosive gastritis by endoscopy within 1 weeks before
 enrollment.

 2. Patients who voluntarily signed written informed consent may participate in the study.

 Exclusion Criteria:

 1. Pregnant or lactating female.

 2. Patients have gastric ulcer, duodenal ulcer and GERD.

 3. Use of any proton pump inhibitor, H2-receptor antagonist, muscarine receptor
 antagonist and gastrin receptor antagonist within 2 weeks before initiating study drug
 therapy

 4. Patients requiring corticosteroid therapy

 5. Severe neurological or psychological disease

 6. History of allergic reaction to the medications used in this study

 7. Use of other investigational drugs within 30 days prior to the study.

 8. Patients that investigators consider ineligible for this study